Additional dosage strengths of Simcor approved - ONA

Links shared publicly online about this topic.

  • 987
    total visits

Additional dosage strengths of Simcor approved - ONA

oncologynurseadvisor.com

Abbott announced that it has received FDA approval for two new dosage strengths of Simcor (niacin extended-release/simvastatin tablets).

View full resource at oncologynurseadvisor.com

Tags: Vitamin, FDA, Niaspan

  • Share

Most Recently Shared on July 29, 2010 at 3:22 pm By:

ONAcom OncologyNurseAdvisor

Additional dosage strengths of Simcor approved http://goo.gl/fb/uixm5

2 years ago...

FDA approves additional strengths of SOLODYN for inflammatory lesions treatment

news-medical.net — “Medicis today announced that the U.S. Food and Drug Administration (FDA) has approved additional strengths of SOLODYN (minocycline HCl, USP) Extended Release Tablets in 55 mg, 80 mg and 105 mg dosages for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 30, 2010 at 5:35 pm By:

Pregnancy_News News-Medical.Net Health News

Pregnancy News: FDA approves additional strengths of SOLODYN for inflammatory lesions treatment: Medicis today ann... http://bit.ly/a30UnM

2 years ago...

Abbott's SIMCOR (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths - QualityPoint Technologies

qualitypointtech.net — “Abbott has received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott's proprietary niacin extended-release and simvastatin, the most commonly used statin. SIMCOR is a prescription medication used along with diet iView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on August 6, 2010 at 2:36 pm By:

MedicalFeed MedicalFeed Health News Feed

Abbott's SIMCOR® (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths: Abbott ... http://bit.ly/av13zh

2 years ago...

Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths

drugs.com — “Simcor (niacin ER and simvastatin) is used for Hyperlipidemia. Information from Drugs.com includes Simcor side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on July 30, 2010 at 1:29 am By:

drugscom Drugs.com Health Site

Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths - http://bit.ly/aBBY2A

2 years ago...

Additional dosage strengths of Simcor approved - MPR

empr.com — “Abbott announced that it has received FDA approval for two new dosage strengths of Simcor (niacin extended-release/simvastatin tablets).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on July 29, 2010 at 4:02 pm By:

eMPR MPR Medical Publisher

MPR News: Additional dosage strengths of Simcor approved: Abbott announced that it has received FDA approval for t... http://bit.ly/bSA16u

2 years ago...

Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin Extended-release/simvastatin)

medicalnewstoday.com — “Abbott has submitted a supplemental new drug application (snda) to the u.s. food and drug administration (fda) for two new dosage strengths of simcor®, a cholesterol medication. simcor is a fiView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 12, 2009 at 12:22 pm By:

HeartsHealth Heart Health Health News

MedicalNewsToday: Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin: http://bit.ly/8fMHnz Full http://bit.ly/78Vmva

2 years ago...

Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin Extended-release/simvastatin)

medicalnewstoday.com — “Abbott (nyse: abt) has submitted a supplemental new drug application (snda) to the u.s. food and drug administration (fda) for two new dosage strengths of simcor®, a cholesterol medication. sView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 11, 2009 at 3:19 pm By:

HeartsHealth Heart Health Health News

MedicalNewsToday: Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin: http://bit.ly/4HlCmF Full http://bit.ly/7vMN53

2 years ago...

Advertisement